MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
Authors
Keywords
Osteosarcoma, miR-451a, AKT/mTOR signaling pathway, m6A methylation
Journal
Journal of Bone Oncology
Volume 33, Issue -, Pages 100412
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.jbo.2022.100412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model
- (2020) Greta Streleckiene et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA CAR10 Upregulates PDPK1 to Promote Cervical Cancer Development by Sponging miR-125b-5p
- (2020) Tingting Hu et al. Biomed Research International
- Epidemiology and Risk Factors of Osteosarcoma
- (2020) Leissan R. Sadykova et al. CANCER INVESTIGATION
- miR‐126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells
- (2020) Rao Fu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
- (2020) Babak Otoukesh et al. Cancer Cell International
- YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven‐center case–control study
- (2020) Huitong Chen et al. JOURNAL OF GENE MEDICINE
- Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
- (2020) Ingrid Lilienthal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphoinositide‐dependent Kinase‐1 (PDPK1) regulates serum/glucocorticoid‐regulated Kinase 3 (SGK3) for prostate cancer cell survival
- (2020) Geetha Nalairndran et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer
- (2019) Ke Xu et al. Cell Death & Disease
- 9za plays cytotoxic and proapoptotic roles and induces cytoprotective autophagy through the PDK1/Akt/mTOR axis in non‐small‐cell lung cancer
- (2019) Rangru Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer
- (2019) Cheng Zhang et al. Cancer Medicine
- mTOR: Role in cancer, metastasis and drug resistance
- (2019) Avaniyapuram Kannan Murugan SEMINARS IN CANCER BIOLOGY
- The Role of miRNA in the Diagnosis, Prognosis, and Treatment of Osteosarcoma
- (2019) Jicheng Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Deciphering miRNAs’ Action through miRNA Editing
- (2019) Marta Correia de Sousa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functions of N6-methyladenosine and its role in cancer
- (2019) Liuer He et al. Molecular Cancer
- miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1
- (2018) Xiuyan Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
- (2017) Ian A Roundtree et al. eLife
- Metastatic osteosarcoma: a challenging multidisciplinary treatment
- (2016) Cristina Meazza et al. Expert Review of Anticancer Therapy
- MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1
- (2016) Zheng Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Update on Survival in Osteosarcoma
- (2016) Megan E. Anderson ORTHOPEDIC CLINICS OF NORTH AMERICA
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
- (2015) Michael S. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway
- (2015) Ismael Riquelme et al. CELLULAR ONCOLOGY
- Differentiating mTOR inhibitors in renal cell carcinoma
- (2013) Sumanta K. Pal et al. CANCER TREATMENT REVIEWS
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells
- (2012) Shingo Kagawa et al. JOURNAL OF SURGICAL RESEARCH
- Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo
- (2011) Lova Segerström et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started